Health Condition 1: N461- Oligospermia
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who fulfill the diagnostic criteria. Patients from any religion, occupation, or socio-economic class. Patients are willing to participate in the study and ready to sign the informed consent form.
Exclusion criteria
Exclusion criteria: Male patients with absolute Azoospermia and Teratozoospermia. Male patients on certain medications like antineoplastic agents (e.g., Nitrogen mustard, procarbazine, vincristine, methotrexate), cimetidine, estrogen and methyltestosterone. Patients have chromosomal disorders like Klinefelter’s syndrome. Patients suffering from major systemic disorders like Tuberculosis, AIDS and sexual Transmitted Diseases (STD) and other gonadal disorders like Testicular Atrophy, Testicular Failure and orchitis, which may interfere with study, will be excluded. Patients having any anatomical deformity in gonads (e.g., Cryptorchidism, Monorchidism)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| After the treatment period, the following symptoms will be checked. Volume Color Concentration pH Viscosity Liquefaction Time Sperm Morphology Vitality Motility Seminal Fructose Sperm CountTimepoint: After 60 days | — |
Secondary
| Measure | Time frame |
|---|---|
| After the treatment period, the following symptoms will be checked. Desire Orgasm Rigidity Erection Ejaculation Post Act ExhaustionTimepoint: On 0th, 31st & 61st days | — |
Countries
India
Contacts
Alvas Ayurveda Medical College